IDEAYA Biosciences (IDYA) Insider Trading & Ownership $16.91 -0.20 (-1.17%) As of 02:04 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IDEAYA Biosciences (NASDAQ:IDYA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$4.83 M Get IDYA Insider Trade Alerts Want to know when executives and insiders are buying or selling IDEAYA Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IDYA Insider Buying and Selling by Quarter Remove Ads IDEAYA Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/29/2024Michael Anthony WhiteinsiderSell28,500$36.24$1,032,840.00 5/16/2024Yujiro S HataCEOSell34,433$41.81$1,439,643.73 5/14/2024Yujiro S HataCEOSell56,711$41.61$2,359,744.71 (Data available from 1/1/2013 forward) IDYA Insider Trading Activity - Frequently Asked Questions Who is on IDEAYA Biosciences's Insider Roster? The list of insiders at IDEAYA Biosciences includes Briseno Andres Ruiz, Jason Throne, Michael Anthony White, Paul A Stone, and Yujiro S Hata. Learn more on insiders at IDYA. What percentage of IDEAYA Biosciences stock is owned by insiders? 3.50% of IDEAYA Biosciences stock is owned by insiders. Learn more on IDYA's insider holdings. Which IDEAYA Biosciences insiders have been selling company stock? The following insiders have sold IDYA shares in the last 24 months: Briseno Andres Ruiz ($320,120.00), Jason Throne ($665,620.78), Michael Anthony White ($1,032,840.00), Paul A Stone ($338,904.56), and Yujiro S Hata ($10,510,580.29). How much insider selling is happening at IDEAYA Biosciences? Insiders have sold a total of 339,118 IDEAYA Biosciences shares in the last 24 months for a total of $12,868,065.63 sold. IDEAYA Biosciences Key ExecutivesMr. Yujiro S. Hata (Age 50)President, CEO & Director Compensation: $912kMr. Andres Ruiz Briseno CPA (Age 38)Principal Accounting Officer, Senior VP and Head of Finance & Investor Relations Compensation: $485.12kDr. Michael A. White Ph.D. (Age 58)Chief Scientific Officer Compensation: $661.8kMr. Jason S. Throne Esq. (Age 52)J.D., Chief Legal Officer & Company Secretary Compensation: $598.8kDr. Darrin M. Beaupre M.D. (Age 57)Ph.D., Chief Medical Officer Compensation: $665.58kDr. Paul A. Barsanti Ph.D.Chief Technology OfficerMr. Mick O'QuigleyChief of Staff & Clinical Development More Insider Trading Tools from MarketBeat Related Companies Blueprint Medicines Insider Trades Sarepta Therapeutics Insider Trades Axsome Therapeutics Insider Trades Krystal Biotech Insider Trades Nuvalent Insider Trades Grifols Insider Trades Elanco Animal Health Insider Trades Verona Pharma Insider Trades ADMA Biologics Insider Trades Cytokinetics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1Casey’s General Stores Insider Buys Shares of This Must-Own StockNVIDIA Insiders Sell: This Is What It Means for the Market This page (NASDAQ:IDYA) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.